CureDuchenne Blog

Google’s Project Euphonia

The Power of Innovation Through Collaboration: Communicating for the Future of Accessible Technology Google’s Project Euphonia is using AI to improve computers’ abilities to understand diverse speech patterns, such as […]


Dyne Therapeutics Series B financing

CureDuchenne congratulates the incredible Dyne Therapeutics team, who recently announced closing $115M in equity financing to develop transformational therapies for patients with serious muscle diseases. We share this news in […]


Letter to the Community – Myosana Therapeutics

Dear Duchenne Community,  I’m truly thrilled about our investment in a new biotech company called Myosana Therapeutics. Myosana aims to develop next-generation gene therapy for Duchenne muscular dystrophy and neuromuscular diseases. Because of this investment, the team is now positioned to conduct […]